Stock listing

Sensei Biotherapeutics, Inc.

Selected listing: 4070 · GETTEX · EUR · DE

Sensei Biotherapeutics, Inc. (gettex:4070), Health Technology. Latest release Jun 15, 2026: Sensei Biotherapeutics Announces Name Change to Faeth…

4070:GETTEXEURDEUpdated August 31, 2026

Ticker: gettex:4070
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: gettex
Currency: EUR

About Sensei Biotherapeutics, Inc.

Sensei Biotherapeutics, Inc. (SNSE) is a public company based in the United States, focused on developing innovative biotherapeutic solutions. Investors can find more information about Sensei Biotherapeutics and its initiatives on its public company page.

Latest news from Sensei Biotherapeutics, Inc.

Sensei Biotherapeutics Announces Name Change to Faeth Therapeutics, Focused on Advancing PIKTOR, an Oral Therapy Targeting One of the Most Frequently Altered Pathways in Cancer

June 15, 2026

Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(4)

June 5, 2026

Sensei Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

May 15, 2026

Sensei Biotherapeutics Doses First Patient in Phase 1b/2 Trial of PIKTOR in HR+/HER2- Advanced Breast Cancer

May 5, 2026

Sensei Biotherapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference

April 9, 2026

All Sensei Biotherapeutics, Inc. news →

Events

Replays

Sensei Biotherapeutics, Inc. (SNSE) Q3 2021 Earnings Call
Tue, Nov 16, 2021 · 04:00 PM ET
Watch

Research Sensei Biotherapeutics, Inc.

Sensei Biotherapeutics, Inc. company profile

View the public company page for Sensei Biotherapeutics, Inc. on 6ix.

Sensei Biotherapeutics, Inc. news

Read company news and market updates connected to Sensei Biotherapeutics, Inc..

Sensei Biotherapeutics, Inc. investor events

Find investor webinars, events, and replay context for Sensei Biotherapeutics, Inc..